The Effects of an Individualized Smartphone-Based Exercise Program on Self-defined Motor Tasks in Parkinson Disease: Pilot Interventional Study.
Heiko Gaßner, Jana Friedrich, Alisa Masuch and 6 others
PMID 36378510WHAT IT FOUND
Fifteen patients with Parkinson disease completed a 4-week home exercise program via a smartphone app.
Usability was good and adherence was high. Patients reported improved personal daily tasks, but standard clinical measures showed no significant change.
Key findings
01The smartphone app was considered usable and feasible, with all 15 participants completing the 4-week program without dropouts.
02Patients reported significant improvement in their self-defined motor tasks for daily life, such as buttoning shirts.
03Standard clinical outcomes, including the UPDRS-III motor score, gait tests, and overall quality of life, did not show statistically significant changes.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study had no control group, so it is impossible to know if the improvements were due to the app, the exercise, or the natural course of the disease. The sample size was very small (15 participants), resulting in low statistical power. The intervention was short (4 weeks), which may have been too brief to detect changes in standard clinical measures like UPDRS-III. Patients continued their normal medication and other therapies, making it difficult to isolate the effect of the smartphone-based exercise.
Declared interests
One author holds ownership in companies related to health technologies and received fees from pharmaceutical companies. Another author reported personal fees from drug companies. Funding included institutional grants from government and research foundations.
The easy way to misread this
Do not conclude that this exercise program is superior to standard care or that it reliably improves clinical motor symptoms. The study lacked a control group, had a very small sample size, and found no significant changes in standard clinical measures like gait or UPDRS-III scores.